Humacyte Inc (HUMA): Congress and insider trades
Who in Congress and inside the company traded HUMA, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Humacyte Inc (HUMA) is a listed stock on NASDAQ.
- 1 member of Congress filed 4 buys and 2 sells of HUMA, the latest published 2026-08-05 (5 August 2026).
- Insiders filed 2 open market buys worth $59.8K and 2 sells worth $82.3K, the latest filed 2026-05-20 (20 May 2026).
- Across 2 scored buys, Congress averaged -42.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion.
- Across 2 scored buys, Insiders averaged -31.8% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in HUMA
as of 2026-08-05| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 5 Aug 2026 | Tommy Tuberville (R-AL) | sell | 15K–50K | 824 | n/a |
| 5 Aug 2026 | Tommy Tuberville (R-AL) | sell | 1K–15K | 824 | n/a |
| 5 Aug 2026 | Tommy Tuberville (R-AL) | buy | 15K–50K | 867 | n/a |
| 5 Aug 2026 | Tommy Tuberville (R-AL) | buy | 1K–15K | 867 | n/a |
| 14 Aug 2023 | Tommy Tuberville (R-AL) | buy | 1K–15K | 20 | -49.5% |
| 8 Apr 2022 | Tommy Tuberville (R-AL) | buy | 15K–50K | 9 | -34.5% |
Nothing matches that search.
Insider trades in HUMA
as of 2026-05-20| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 20 May 2026 | Sebelius Kathleen | buy | 56,818 | $0.88 | $50.0K | -31.8% |
| 20 May 2026 | Sander Dale A. | sell | 45,887 | $0.90 | $41.1K | n/a |
| 20 May 2026 | Parikh Shamik J | sell | 45,887 | $0.90 | $41.1K | n/a |
| 20 May 2026 | Constantino Michael T. | buy | 11,000 | $0.89 | $9.8K | -31.8% |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought HUMA?
4 Congress buys by 1 member and 2 insider buys are on file. The tables on this page list every one.
Did buying HUMA after a disclosure beat the market?
Across 2 scored buys, Congress averaged -42.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion. Across 2 scored buys, Insiders averaged -31.8% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.